This page is no longer updated.
It was archived on 8 July 2008 and is kept for historical purposes only. The latest content is available at http://www.who.int/selection_medicines/en/
![]() |
WHO/UNICEF |
|
|
Venue:
WHO
Headquarters, |
||||
| Key readings | Draft Programme | PPT Presentations |
|
|
|
Monday 19 September
2005 |
||||
| Registration |
08.45-09.00 |
Salle G, Main building (8th floor) | ||
| Introduction | ||||
|
09.00-09.30
|
Welcome -
Objectives of the Seminar
Hans Hogerzeil, Director PSM Precious Matsoso, Director TCM |
|
||
| 09.30-10.15
|
Introduction of
participants: Gallery of experts Zafar Mirza, RA/EMRO |
|||
| 10.15-10.45 | Coffee | |||
| 10.45-11.00 | Seminar
overview and administration Richard Laing, PSM/PAR Lalit Dwivedi, PSM/PAR |
|||
| 11.00-12.30 | PSM and TCM roles and responsibilities in implementing the WHO Medicines Strategy | |||
| Hans Hogerzeil, Director PSM | ||||
| Precious Matsoso, Director TCM | ||||
| 12.30-14.00 | Lunch | |||
| National Drug Policies | ||||
| 14.00-14.30 | National Medicines
Policies Richard Laing, PSM/PAR Hans Hogerzeil, Director PSM |
|||
| Selection of Essential Medicines | ||||
| 14.30-15.30 | Update 2005 WHO
Model List of Essential Medicines Selection, evidence-based approach Hans Hogerzeil, Director PSM |
|||
| 15.45-16.00 | Tea | |||
| Information resources | ||||
| 16.00-17.00 | Documentation
Centre, Essential Medicines Library & Bookshelf, WHO Model Formulary
Claude Da Re, TCM Lalit Dwivedi, PSM/PAR |
|||
| 17.30-19.00 | Reception with
Assistant Director General, WHO/HTP Cluster and PSM & TCM staff
members (WHO Restaurant, Main Building) |
|||
|
Tuesday 20 September
2005 |
Top of page | |||
| What is quality? | ||||
| 09.00-12.30 | Medicine/Drug
regulation and quality assurance WHO normative functions in the field of
pharmaceuticals Lembit Rago, PSM/QSM |
|||
| Sabine Kopp, PSM/QSM |
Drug Regulation and Quality Assurance: - WHO normative functions in the
field of pharmaceuticals |
|||
| Assessment of
regulatory capacity at country level including 10 country study Valerio Reggi, PSM/QSM Eshetu Wondemagegnehu, PSM/QSM |
||||
| 10.45-11-00 | Coffee | |||
| 12.30-14.00 | Lunch | |||
| Prequalification | ||||
| 14.00-15.30 | Prequalification
of essential medicines Lembit Rago, PSM/QSM Olivier Gross, PSM/QSM |
|
||
| 15.30-15.45
|
Tea | |||
| Global issues | ||||
|
15.45-17.00
|
Impact of
globalization, international trade agreements, Doha, Cancun German Velásquez, Associate Director TCM Cecilia Oh, TCM/DAP |
|||
|
Wednesday 21 September
2005 |
Top of page | |||
| What is access? | ||||
| 09.00-11.30 | Access framework, HIV/AIDS, TB and Malaria | |||
| Clive Ondari, PSM/PAR | ||||
| Marthe Everard, PSM/PAR | ||||
| Helen Tata, TCM/DAP | ||||
| Peter Graaff, WHO/HIV | ||||
| Paul Matiru, GDF-TB |
|
|||
| Murtada Sesay, UNICEF | ||||
| Luca Di Bassi, Global Fund for AIDS, TB and Malaria | ||||
| Short presentations + Panel discussion | ||||
| 10.30-10.45 | Coffee | |||
| 11.30-12.30 | Essential Medicines as a
Human Right Hans Hogerzeil, Director PSM |
|||
| 12.30-14.00
|
Lunch | |||
| Medicine Prices and Financing | ||||
| 14.00-15.45 | Medicine prices, WHO/NGO
Price Survey Methodology Richard Laing, PSM/PAR Gilles Forte, TCM/DAP |
The
prices of medicines measurement methodology and findings in countries |
||
| 15.45-16.00 | Tea | |||
| Medicines promotion | ||||
| 16.00-17.30 | Hot Topics (to be revised based on participant interest) Key issues in access and best practices: MDGs; private sector (OTC/prescriptions); human resources; medical education curricula; medicines promotion and ethical criteria; special needs in small countries |
|
||
| Richard Laing, PSM/PAR | ||||
| Zafar Mirza, RA/EMRO | ||||
| Guitelle Baghdadi, PSM/PAR | ||||
| Pramod Samantaray, UNFPA Consultant (Trg) & National Consultant, India |
Medicines Promotion/Key intervention in Access and client friendly Health care delivery in India |
|||
| Evening
|
Dinner, Geneva (Optional: all have to pay for themselves: sorry!) |
|||
|
Thursday 22 September
2005 |
Top of page | |||
| Country programmes | ||||
| 09.00-09.30 | WHO
Strategy for working with and in countries
Gilles Forte, TCM/DAP |
Technical cooperation with countries | ||
| 09.30-10.45 | TCM
strategy for working with countries - regional and country perspective Jean-Marie Trapsida, WHO/AFRO TCM Team |
WHO strategy for working with countries: Regional and country perspective | ||
| 10.45-11.00 |
Coffee |
|||
| 11.00-12.30 |
EDM strategy for working
with countries - the experience of Kenya
|
Evaluation and Monitoring of Country Implementation of Work:Addressing Common Problems | ||
| Regina Mbindyo, WHO/AFRO | WHO Medicines Work in Countries: The Kenya Example | |||
|
12.30-14.00 |
Lunch | |||
| Monitoring | ||||
| 14.00-15.30 |
Indicators on
pharmaceutical situations |
Using indicators to measure country pharmaceutical situations | ||
| 15.30-15.45 |
Tea |
|||
| Traditional Medicine | ||||
|
16.00-17.30
|
International
harmonization focus on the regulatory requirements for quality and safety
of herbal medicines
Samvel Azatyan, TCM/TRM |
|||
|
Friday 23 September
2005 |
Top of page | |||
| Safety | ||||
|
09.00-10.00 |
Pharmacovigilance: New
challenges for WHO Mary Couper, PSM/QSM Shanthi Pal, PSM/QSM |
Pharmacovigilance |
||
| What is rational medicine use? | ||||
|
10.00-12.30 |
Promoting rational
medicine
Kathleen Holloway, PSM/PAR |
Rational Use of Drugs: an Overview | ||
|
10.45-11.00 |
Coffee |
|||
| 12.30 | Closure | |||
| 14.00 | Additional time for sessions, individual appointments with TCM/PSM staff | |||